Suppr超能文献

相似文献

1
Lymphocytes, neuropeptides, and genes involved in alopecia areata.
J Clin Invest. 2007 Aug;117(8):2019-27. doi: 10.1172/JCI31942.
2
Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
Autoimmun Rev. 2006 Jan;5(1):64-9. doi: 10.1016/j.autrev.2005.07.001. Epub 2005 Aug 8.
3
Alopecia areata: autoimmunity--the evidence is compelling.
J Investig Dermatol Symp Proc. 2003 Oct;8(2):164-7. doi: 10.1046/j.1087-0024.2003.00802.x.
4
An update on alopecia areata.
Curr Opin Pediatr. 2009 Aug;21(4):475-80. doi: 10.1097/MOP.0b013e32832db986.
6
Alopecia areata: a review of disease pathogenesis.
Br J Dermatol. 2018 Nov;179(5):1033-1048. doi: 10.1111/bjd.16808. Epub 2018 Sep 9.
7
Role of neurogenic inflammation in the pathogenesis of alopecia areata.
J Dermatol. 2024 May;51(5):621-631. doi: 10.1111/1346-8138.17227. Epub 2024 Apr 11.
9
Alopecia areata.
Curr Dir Autoimmun. 2008;10:280-312. doi: 10.1159/000131749.

引用本文的文献

1
The Diverse Experiences and Challenges of Individuals With Alopecia Areata: Survey Results From Finland.
J Patient Exp. 2025 Jun 3;12:23743735251346633. doi: 10.1177/23743735251346633. eCollection 2025.
3
Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme.
J Eur Acad Dermatol Venereol. 2025 Jun;39(6):1163-1173. doi: 10.1111/jdv.20547. Epub 2025 Feb 17.
4
Pathogenesis and regenerative therapy in vitiligo and alopecia areata: focus on hair follicle.
Front Med (Lausanne). 2025 Jan 15;11:1510363. doi: 10.3389/fmed.2024.1510363. eCollection 2024.
7
Good efficacy achieved by telitacicept in treatment of systemic lupus erythematosus with alopecia areata.
Arch Med Sci. 2024 Jun 30;20(3):1050-1052. doi: 10.5114/aoms/188860. eCollection 2024.
10
Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences.
Int J Mol Sci. 2024 Apr 17;25(8):4409. doi: 10.3390/ijms25084409.

本文引用的文献

1
NALP1 in vitiligo-associated multiple autoimmune disease.
N Engl J Med. 2007 Mar 22;356(12):1216-25. doi: 10.1056/NEJMoa061592.
2
Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata).
J Invest Dermatol. 2007 Jun;127(6):1489-97. doi: 10.1038/sj.jid.5700704. Epub 2007 Feb 1.
3
Alopecia areata.
Int J Dermatol. 2007 Feb;46(2):121-31. doi: 10.1111/j.1365-4632.2007.03193.x.
4
Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata.
Am J Hum Genet. 2007 Feb;80(2):316-28. doi: 10.1086/511442. Epub 2007 Jan 5.
5
Immune privilege induced by regulatory T cells in transplantation tolerance.
Immunol Rev. 2006 Oct;213:239-55. doi: 10.1111/j.1600-065X.2006.00428.x.
6
TGF-beta: a mobile purveyor of immune privilege.
Immunol Rev. 2006 Oct;213:213-27. doi: 10.1111/j.1600-065X.2006.00437.x.
7
A historical perspective on immunological privilege.
Immunol Rev. 2006 Oct;213:12-22. doi: 10.1111/j.1600-065X.2006.00434.x.
8
Immunology: protection and privilege.
Nature. 2006 Aug 31;442(7106):987-8. doi: 10.1038/nature05165. Epub 2006 Aug 20.
9
Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance.
J Invest Dermatol. 2006 Sep;126(9):1937-47. doi: 10.1038/sj.jid.5700429.
10
Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
Br J Dermatol. 2006 Sep;155(3):515-21. doi: 10.1111/j.1365-2133.2006.07377.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验